Skip to main content

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 11, Number 22, August 2005

Book review

Favourites:
ADD

Review article

DNA Drug Design for Cancer Therapy
pp. 2811-2823(13)
Author: Cho-Chung, Y. S.

Favourites:
ADD

Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond
pp. 2825-2840(16)
Authors: Coppelli, F. M.; Grandis, J. R.

Favourites:
ADD

Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents
pp. 2841-2854(14)
Authors: Jing, N.; Sha, W.; Li, Y.; Xiong, W.; Tweardy, D. J.

Favourites:
ADD

Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale
pp. 2855-2572
Authors: Pommier, Y.; Sordet, O.; Rao, A.; Zhang, H.; Kohn, K. W.

Favourites:
ADD

Targeting Transcription Factors for Cancer Therapy
pp. 2873-2887(15)
Authors: Redell, M. S.; Tweardy, D. J.

Favourites:
ADD

Bacterial Toxins: Potential Weapons Against HIV Infection
pp. 2909-2926(18)
Authors: Alfano, M.; Rizzi, C.; Corti, D.; Adduce, L.; Poli, G.

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more